FIA
ABBV icon

FPC Investment Advisory’s AbbVie ABBV Stock Holding History

FPC Investment Advisory’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$380K Buy
1,910
+2
+0.1% +$444 0.19% 23
2025
Q4 		$436K Hold
1,908
– – 0.24% 22
2025
Q3 		$442K Hold
1,908
– – 0.27% 19
2025
Q2 		$365K Sell
1,908
-307
-14% -$57.1K 0.23% 21
2025
Q1 		$434K Buy
2,215
+2,097
+1,777% +$408K 0.3% 19
2024
Q4 		$21.7K Buy
+118
New +$21.7K 0.02% 94

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FPC Investment Advisory's ABBV Position: Q1 2026 in Review

FPC Investment Advisory increased its AbbVie (ABBV) stake by 0.1% in Q1 2026, buying an estimated $444 and bringing the position to 1,910 shares worth $380K. The position accounts for 0.19% of the portfolio, ranked #23.

FPC Investment Advisory first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $442K in Q3 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • FPC Investment Advisory held 1,910 shares of AbbVie worth $380K as of Q1 2026.
  • FPC Investment Advisory bought 2 AbbVie shares in Q1 2026, an estimated $444.
  • AbbVie made up 0.19% of FPC Investment Advisory's portfolio in Q1 2026, its #23 holding.
  • FPC Investment Advisory first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • FPC Investment Advisory's AbbVie position peaked at $442K in Q3 2025.
  • 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on FPC Investment Advisory's 13F filing for Q1 2026, filed 4 May 2026.